Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Systematic review and multi-modal meta-analysis of magnetic resonance imaging findings in 22q11.2 deletion syndrome: Is more evidence needed?

Scarpazza C, Lattanzi GM, Antoniades M, Di Fabio F, Sartori G, Eickhoff SB, McGuire P, Tognin S.

Neurosci Biobehav Rev. 2019 Sep 4;107:143-153. doi: 10.1016/j.neubiorev.2019.09.004. [Epub ahead of print] Review.

PMID:
31493414
2.

Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics.

Lei D, Pinaya WHL, van Amelsvoort T, Marcelis M, Donohoe G, Mothersill DO, Corvin A, Gill M, Vieira S, Huang X, Lui S, Scarpazza C, Young J, Arango C, Bullmore E, Qiyong G, McGuire P, Mechelli A.

Psychol Med. 2019 Aug 8:1-10. doi: 10.1017/S0033291719001934. [Epub ahead of print]

PMID:
31391132
3.

Four cases of natalizumab-related PML: a less severe course in extended interval dosing?

Scarpazza C, De Rossi N, Tabiadon G, Turrini MV, Gerevini S, Capra R.

Neurol Sci. 2019 Oct;40(10):2119-2124. doi: 10.1007/s10072-019-03959-4. Epub 2019 Jun 7.

PMID:
31175467
4.

Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debate.

Scarpazza C, Signori A, Cosottini M, Sormani MP, Gerevini S, Capra R.

Mult Scler. 2019 May 30:1352458519854162. doi: 10.1177/1352458519854162. [Epub ahead of print]

PMID:
31144589
5.

Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes.

Morgan SE, Seidlitz J, Whitaker KJ, Romero-Garcia R, Clifton NE, Scarpazza C, van Amelsvoort T, Marcelis M, van Os J, Donohoe G, Mothersill D, Corvin A, Pocklington A, Raznahan A, McGuire P, Vértes PE, Bullmore ET.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9604-9609. doi: 10.1073/pnas.1820754116. Epub 2019 Apr 19.

6.

Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence.

Vieira S, Gong QY, Pinaya WHL, Scarpazza C, Tognin S, Crespo-Facorro B, Tordesillas-Gutierrez D, Ortiz-García V, Setien-Suero E, Scheepers FE, Van Haren NEM, Marques TR, Murray RM, David A, Dazzan P, McGuire P, Mechelli A.

Schizophr Bull. 2019 Feb 27. pii: sby189. doi: 10.1093/schbul/sby189. [Epub ahead of print]

PMID:
30809667
7.

Fear-specific enhancement of tactile perception is disrupted after amygdala lesion.

Bertini C, Starita F, Passamonti C, Santoro F, Zamponi N, Michelucci R, Scarpazza C.

J Neuropsychol. 2019 Feb 4. doi: 10.1111/jnp.12178. [Epub ahead of print]

PMID:
30714317
8.

Where is the "where" in the brain? A meta-analysis of neuroimaging studies on spatial cognition.

Cona G, Scarpazza C.

Hum Brain Mapp. 2019 Apr 15;40(6):1867-1886. doi: 10.1002/hbm.24496. Epub 2019 Jan 1.

PMID:
30600568
9.

Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution.

Scarpazza C, Signori A, Prosperini L, Sormani MP, Cosottini M, Capra R, Gerevini S; Italian PML Group.

J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):261-267. doi: 10.1136/jnnp-2018-319208. Epub 2018 Nov 2.

PMID:
30389778
10.

The charm of structural neuroimaging in insanity evaluations: guidelines to avoid misinterpretation of the findings.

Scarpazza C, Ferracuti S, Miolla A, Sartori G.

Transl Psychiatry. 2018 Oct 26;8(1):227. doi: 10.1038/s41398-018-0274-8. Review.

11.

A transdiagnostic neuroanatomical signature of psychiatric illness.

Gong Q, Scarpazza C, Dai J, He M, Xu X, Shi Y, Zhou B, Vieira S, McCrory E, Ai Y, Yang C, Zhang F, Lui S, Mechelli A.

Neuropsychopharmacology. 2019 Apr;44(5):869-875. doi: 10.1038/s41386-018-0175-9. Epub 2018 Aug 8.

12.

Neuropsychological profile of mild temporal lobe epilepsy.

Vaccaro MG, Trimboli M, Scarpazza C, Palermo L, Bruni A, Gambardella A, Labate A.

Epilepsy Behav. 2018 Aug;85:222-226. doi: 10.1016/j.yebeh.2018.06.013. Epub 2018 Jul 2.

PMID:
30032811
13.

Alexithymia Is Related to the Need for More Emotional Intensity to Identify Static Fearful Facial Expressions.

Starita F, Borhani K, Bertini C, Scarpazza C.

Front Psychol. 2018 Jun 11;9:929. doi: 10.3389/fpsyg.2018.00929. eCollection 2018.

14.

The Detection of Malingering: A New Tool to Identify Made-Up Depression.

Monaro M, Toncini A, Ferracuti S, Tessari G, Vaccaro MG, De Fazio P, Pigato G, Meneghel T, Scarpazza C, Sartori G.

Front Psychiatry. 2018 Jun 8;9:249. doi: 10.3389/fpsyt.2018.00249. eCollection 2018.

15.

Mental Insanity Assessment of Pedophilia: The Importance of the Trans-Disciplinary Approach. Reflections on Two Cases.

Scarpazza C, Pennati A, Sartori G.

Front Neurosci. 2018 May 16;12:335. doi: 10.3389/fnins.2018.00335. eCollection 2018.

17.

Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

Mancinelli CR, Scarpazza C, Santuccio G, De Rossi N, Capra R.

Neurol Sci. 2018 May;39(5):965-966. doi: 10.1007/s10072-017-3228-7. Epub 2018 Jan 4. No abstract available.

PMID:
29302813
18.

Invisible side of emotions: somato-motor responses to affective facial displays in alexithymia.

Scarpazza C, Làdavas E, Cattaneo L.

Exp Brain Res. 2018 Jan;236(1):195-206. doi: 10.1007/s00221-017-5118-x. Epub 2017 Nov 17.

PMID:
29150757
19.

To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy.

Scarpazza C, Prosperini L, De Rossi N, Moiola L, Sormani MP, Gerevini S, Capra R; Italian PML group.

Ann Neurol. 2017 Nov;82(5):697-705. doi: 10.1002/ana.25070. Epub 2017 Oct 31.

PMID:
29023856
20.

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237].

Scarpazza C, Prosperini L, Mancinelli CR, De Rossi N, Lugaresi A, Capobianco M, Moiola L, Naldi P, Imberti L, Gerevini S, Capra R.

J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4. No abstract available.

PMID:
28870565
21.

Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.

Prosperini L, Scarpazza C, Imberti L, Cordioli C, De Rossi N, Capra R.

J Neurovirol. 2017 Oct;23(5):742-749. doi: 10.1007/s13365-017-0561-9. Epub 2017 Aug 8.

PMID:
28791614
22.

Multiple sclerosis reduces sensitivity to immediate reward during decision making.

Grippa E, Sellitto M, Scarpazza C, Mattioli F, di Pellegrino G.

Behav Neurosci. 2017 Aug;131(4):325-336. doi: 10.1037/bne0000206.

PMID:
28714718
23.

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?

Scarpazza C, Prosperini L, Mancinelli CR, De Rossi N, Lugaresi A, Capobianco M, Moiola L, Naldi P, Imberti L, Gerevini S, Capra R.

J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12. Erratum in: J Neurol Sci. 2017 Sep 15;380:19.

PMID:
28566170
24.

Subjective recollection independent from multifeatural context retrieval following damage to the posterior parietal cortex.

Ciaramelli E, Faggi G, Scarpazza C, Mattioli F, Spaniol J, Ghetti S, Moscovitch M.

Cortex. 2017 Jun;91:114-125. doi: 10.1016/j.cortex.2017.03.015. Epub 2017 Apr 1.

PMID:
28449939
25.

Now or not-now? The influence of alexithymia on intertemporal decision-making.

Scarpazza C, Sellitto M, di Pellegrino G.

Brain Cogn. 2017 Jun;114:20-28. doi: 10.1016/j.bandc.2017.03.001. Epub 2017 Mar 21.

PMID:
28334633
26.

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.

Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D; Italian PML study group.

Neurology. 2017 Mar 21;88(12):1144-1152. doi: 10.1212/WNL.0000000000003740. Epub 2017 Feb 22.

27.

The guilty brain: the utility of neuroimaging and neurostimulation studies in forensic field.

Mameli F, Scarpazza C, Tomasini E, Ferrucci R, Ruggiero F, Sartori G, Priori A.

Rev Neurosci. 2017 Feb 1;28(2):161-172. doi: 10.1515/revneuro-2016-0048. Review.

PMID:
28030362
28.

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.

Prosperini L, de Rossi N, Scarpazza C, Moiola L, Cosottini M, Gerevini S, Capra R; Italian PML study group.

PLoS One. 2016 Dec 20;11(12):e0168376. doi: 10.1371/journal.pone.0168376. eCollection 2016.

29.

Error monitoring is related to processing internal affective states.

Maier ME, Scarpazza C, Starita F, Filogamo R, Làdavas E.

Cogn Affect Behav Neurosci. 2016 Dec;16(6):1050-1062.

PMID:
27540740
30.

Effects of cue focality on the neural mechanisms of prospective memory: A meta-analysis of neuroimaging studies.

Cona G, Bisiacchi PS, Sartori G, Scarpazza C.

Sci Rep. 2016 May 17;6:25983. doi: 10.1038/srep25983.

31.

An unusual case of acquired pedophilic behavior following compression of orbitofrontal cortex and hypothalamus by a Clivus Chordoma.

Sartori G, Scarpazza C, Codognotto S, Pietrini P.

J Neurol. 2016 Jul;263(7):1454-5. doi: 10.1007/s00415-016-8143-y. Epub 2016 May 9. No abstract available.

PMID:
27159984
32.

When the Single Matters more than the Group (II): Addressing the Problem of High False Positive Rates in Single Case Voxel Based Morphometry Using Non-parametric Statistics.

Scarpazza C, Nichols TE, Seramondi D, Maumet C, Sartori G, Mechelli A.

Front Neurosci. 2016 Jan 25;10:6. doi: 10.3389/fnins.2016.00006. eCollection 2016.

33.

Dissociation between Emotional Remapping of Fear and Disgust in Alexithymia.

Scarpazza C, Làdavas E, di Pellegrino G.

PLoS One. 2015 Oct 13;10(10):e0140229. doi: 10.1371/journal.pone.0140229. eCollection 2015.

34.

A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups.

Gong Q, Dazzan P, Scarpazza C, Kasai K, Hu X, Marques TR, Iwashiro N, Huang X, Murray RM, Koike S, David AS, Yamasue H, Lui S, Mechelli A.

Schizophr Bull. 2015 Nov;41(6):1266-75. doi: 10.1093/schbul/sbv109. Epub 2015 Aug 11.

35.

Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.

Mattioli F, Stampatori C, Bellomi F, Scarpazza C, Capra R.

PLoS One. 2015 Jul 6;10(7):e0131803. doi: 10.1371/journal.pone.0131803. eCollection 2015.

36.

Neural bases of prospective memory: a meta-analysis and the "Attention to Delayed Intention" (AtoDI) model.

Cona G, Scarpazza C, Sartori G, Moscovitch M, Bisiacchi PS.

Neurosci Biobehav Rev. 2015 May;52:21-37. doi: 10.1016/j.neubiorev.2015.02.007. Epub 2015 Feb 19. Review.

PMID:
25704073
37.

False positive rates in Voxel-based Morphometry studies of the human brain: should we be worried?

Scarpazza C, Tognin S, Frisciata S, Sartori G, Mechelli A.

Neurosci Biobehav Rev. 2015 May;52:49-55. doi: 10.1016/j.neubiorev.2015.02.008. Epub 2015 Feb 19. Review.

38.

Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population.

Mattioli F, Stampatori C, Bellomi F, Scarpazza C, Galli P, Guarneri C, Corso B, Montomoli C, Niccolai C, Goretti B, Amato MP, Riboni E, Tomasina CD, Falautano M, Capra R.

Neurol Sci. 2014 Dec;35(12):1895-902. doi: 10.1007/s10072-014-1857-7. Epub 2014 Jul 6.

PMID:
24998015
39.

Emotional modulation of touch in alexithymia.

Scarpazza C, di Pellegrino G, Làdavas E.

Emotion. 2014 Jun;14(3):602-10. doi: 10.1037/a0035888. Epub 2014 Apr 7.

PMID:
24708501
40.

Early aphasia rehabilitation is associated with functional reactivation of the left inferior frontal gyrus: a pilot study.

Mattioli F, Ambrosi C, Mascaro L, Scarpazza C, Pasquali P, Frugoni M, Magoni M, Biagi L, Gasparotti R.

Stroke. 2014 Feb;45(2):545-52. doi: 10.1161/STROKEAHA.113.003192. Epub 2013 Dec 5.

PMID:
24309584
41.

Observed touch on a non-human face is not remapped onto the human observer's own face.

Beck B, Bertini C, Scarpazza C, Làdavas E.

PLoS One. 2013 Nov 8;8(11):e73681. doi: 10.1371/journal.pone.0073681. eCollection 2013.

42.

The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.

Goretti B, Patti F, Cilia S, Mattioli F, Stampatori C, Scarpazza C, Amato MP, Portaccio E.

Neurol Sci. 2014 Jan;35(1):79-82. doi: 10.1007/s10072-013-1558-7. Epub 2013 Oct 8.

PMID:
24101117
43.

Education protects against cognitive changes associated with multiple sclerosis.

Scarpazza C, Braghittoni D, Casale B, Malagú S, Mattioli F, di Pellegrino G, Ladavas E.

Restor Neurol Neurosci. 2013;31(5):619-31. doi: 10.3233/RNN-120261.

PMID:
23735315
44.

When the single matters more than the group: very high false positive rates in single case Voxel Based Morphometry.

Scarpazza C, Sartori G, De Simone MS, Mechelli A.

Neuroimage. 2013 Apr 15;70:175-88. doi: 10.1016/j.neuroimage.2012.12.045. Epub 2013 Jan 2.

PMID:
23291189
45.

Persistence of the effects of attention and executive functions intensive rehabilitation in relapsing remitting multiple sclerosis.

Mattioli F, Stampatori C, Scarpazza C, Parrinello G, Capra R.

Mult Scler Relat Disord. 2012 Oct;1(4):168-73. doi: 10.1016/j.msard.2012.06.004. Epub 2012 Jul 21.

PMID:
25877265
46.

General intellectual impairment in chronic right hemisphere damaged patients with anosognosia: a group study.

Mattioli F, Gialanella B, Stampatori C, Scarpazza C.

Neuropsychol Rehabil. 2012;22(4):501-15. doi: 10.1080/09602011.2012.662340. Epub 2012 Feb 23.

PMID:
22360272
47.

Prognostic prediction of therapeutic response in depression using high-field MR imaging.

Gong Q, Wu Q, Scarpazza C, Lui S, Jia Z, Marquand A, Huang X, McGuire P, Mechelli A.

Neuroimage. 2011 Apr 15;55(4):1497-503. doi: 10.1016/j.neuroimage.2010.11.079. Epub 2010 Dec 3.

PMID:
21134472
48.

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.

Lorenzi M, Donohue M, Paternicò D, Scarpazza C, Ostrowitzki S, Blin O, Irving E, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1443-51, 1451.e1. doi: 10.1016/j.neurobiolaging.2010.04.036. Epub 2010 Jun 11.

PMID:
20541287

Supplemental Content

Loading ...
Support Center